Vanesa Ortiz
Overview
Explore the profile of Vanesa Ortiz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Slavova D, Ortiz V, Blaise M, Bairachnaya M, Giros B, Isingrini E
Neurosci Biobehav Rev
. 2024 Oct;
167:105925.
PMID: 39427811
Stressful events, from daily stressors to traumatic experiences, are common and occur at any age. Despite the high prevalence of trauma, not everyone develops stress-related disorders like major depressive disorder...
2.
Ortiz V, Campos R, Fofo H, Fernandez S, Barik J
Neuropsychopharmacology
. 2022 Apr;
47(9):1587-1596.
PMID: 35459925
There are about twice as many women as men who experience depression during their lifetime. Although life circumstances and especially exposure to stressful situations constitute a major risk factor to...
3.
Allichon M, Ortiz V, Pousinha P, Andrianarivelo A, Petitbon A, Heck N, et al.
Front Synaptic Neurosci
. 2021 Dec;
13:799274.
PMID: 34970134
Drug addiction is defined as a compulsive pattern of drug-seeking- and taking- behavior, with recurrent episodes of abstinence and relapse, and a loss of control despite negative consequences. Addictive drugs...
4.
Andrianarivelo A, Saint-Jour E, Pousinha P, Fernandez S, Petitbon A, De Smedt-Peyrusse V, et al.
Sci Adv
. 2021 Oct;
7(43):eabg5970.
PMID: 34669474
Addictive drugs increase dopamine in the nucleus accumbens (NAc), where it persistently shapes excitatory glutamate transmission and hijacks natural reward processing. Here, we provide evidence, from mice to humans, that...
5.
Espejo P, Ortiz V, Martijena I, Molina V
Neurobiol Learn Mem
. 2021 Jan;
179:107386.
PMID: 33476748
The destabilization/reconsolidation process can be triggered by memory recall, allowing consolidated memories to be modified. We have previously reported that stress prior to fear conditioning induces memories that exhibit resistance...
6.
Ortiz V, Calfa G, Molina V, Martijena I
Prog Neuropsychopharmacol Biol Psychiatry
. 2019 Apr;
93:197-204.
PMID: 30978427
Fear memory reactivation does not always lead to memory destabilization-reconsolidation. For instance, fear memories formed following withdrawal from chronic ethanol consumption or a stressful event are less likely to become...
7.
Ortiz V, Espejo P, Molina V, Martijena I
Prog Neuropsychopharmacol Biol Psychiatry
. 2018 Aug;
89:9-15.
PMID: 30145183
A 1-day fear memory in ethanol withdrawn (ETOH) rats is resistant to destabilization-reconsolidation process. However, d-cycloserine (DCS) reverts this disturbance. Considering that the formation of pathological fear memories in humans...
8.
Espejo P, Ortiz V, Martijena I, Molina V
Neurobiol Learn Mem
. 2017 Jul;
144:166-173.
PMID: 28669783
It is well known that stress can affect mnemonic processes. In particular, stress before contextual fear conditioning induces a memory which exhibits resistance to being interfered with by Midazolam (MDZ)...
9.
Ortiz V, Molina V, Martijena I
Behav Brain Res
. 2016 Aug;
315:66-70.
PMID: 27522017
The pharmacological blockade of memory reconsolidation has been suggested as a potential treatment to the attenuation of maladaptive memories associated to psychiatric disorders and drug addiction. To interfere with the...
10.
Espejo P, Ortiz V, Martijena I, Molina V
Neuropharmacology
. 2016 Jul;
109:349-356.
PMID: 27378335
Consolidated memories can enter into a labile state after reactivation followed by a restabilization process defined as reconsolidation. This process can be interfered with Midazolam (MDZ), a positive allosteric modulator...